1.1599
price down icon1.44%   -0.0299
 
loading

Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten

pulisher
02:23 AM

What analysts say about Clearmind Medicine Inc. stockPowerful growth strategies - Autocar Professional

02:23 AM
pulisher
10:20 AM

Clearmind Medicine Inc Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - MarketScreener

10:20 AM
pulisher
09:18 AM

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - The Manila Times

09:18 AM
pulisher
09:07 AM

Clearmind advances AUD treatment with new trial site in Tel Aviv - Investing.com

09:07 AM
pulisher
Jul 22, 2025

Is Clearmind Medicine Inc. a good long term investmentGame-changing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Clearmind Medicine Inc. stock priceOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Clearmind Medicine Inc. Stock Analysis and ForecastFree Capital Growth Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Clearmind Medicine Surges 18.99%: What's Fueling This Volatile Biotech Rally? - AInvest

Jul 21, 2025
pulisher
Jul 20, 2025

How Clearmind Medicine Inc. stock reacts to Fed policy changesFree Access to Community with 300% Return - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

What makes Clearmind Medicine Inc. stock price move sharplySmart Money Trade Setups - beatles.ru

Jul 16, 2025
pulisher
Jul 16, 2025

Clearmind Expands its Clinical Trial for Alcohol Use, New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 16, 2025
pulisher
Jul 15, 2025

How Clearmind Medicine Inc. stock performs during market volatilityFree High-Accuracy Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Clearmind Medicine Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Expands Its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 to Johns Hopkins University to Address Alcohol Use Disorder - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - The Manila Times

Jul 15, 2025
pulisher
Jul 09, 2025

Clearmind Medicine (NASDAQ:CMND) Stock Price Up 4.5% – Here’s Why - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck - Yahoo Finance

Jul 09, 2025
pulisher
Jul 04, 2025

Clearmind Medicine Soars 32.89% on Clinical Trial Approval - AInvest

Jul 04, 2025
pulisher
Jul 03, 2025

CMND’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial - Nasdaq

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind’s Stock Gains Momentum with New Trial Expansions - timothysykes.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind Medicine’s Rise: What’s Steering the Surge? - timothysykes.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind receives IRB approval for alcohol disorder treatment trial - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind receives IRB approval for alcohol disorder treatment trial By Investing.com - Investing.com South Africa

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind Medicine Inc. Receives IRB Approval for Phase 1/2a Clinical Trial of CMND-100 for Alcohol Use Disorder - Nasdaq

Jul 03, 2025
pulisher
Jun 30, 2025

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder - The Manila Times

Jun 30, 2025
pulisher
Jun 30, 2025

Clearmind doses first participant in alcohol disorder treatment trial - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Clearmind doses first participant in alcohol disorder treatment trial By Investing.com - Investing.com Canada

Jun 30, 2025
pulisher
Jun 28, 2025

Clearmind Medicine's Global AUD Trial Expansion: Seizing the $775M Market's Psychedelic Opportunity - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

Clearmind adds Hadassah Medical Center to alcohol disorder drug trial By Investing.com - Investing.com South Africa

Jun 27, 2025
pulisher
Jun 27, 2025

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market - The Manila Times

Jun 27, 2025
pulisher
Jun 25, 2025

Clearmind enrolls first patient in CMND-100 alcohol disorder trial - Investing.com India

Jun 25, 2025
pulisher
Jun 25, 2025

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

Clearmind Medicine Inc. Engages Consulting Firm to Advance Psychedelic-Based Treatments and Regulatory Advocacy - Nasdaq

Jun 24, 2025
$22.84
price up icon 4.74%
$36.04
price down icon 0.14%
$102.98
price down icon 0.01%
$27.88
price up icon 5.03%
$113.83
price up icon 2.13%
biotechnology ONC
$294.48
price down icon 0.29%
Kapitalisierung:     |  Volumen (24h):